296 related articles for article (PubMed ID: 33548732)
1. Swertiamarin from Enicostemma littorale, counteracts PD associated neurotoxicity via enhancement α-synuclein suppressive genes and SKN-1/NRF-2 activation through MAPK pathway.
Pandey T; Shukla A; Trivedi M; Khan F; Pandey R
Bioorg Chem; 2021 Mar; 108():104655. PubMed ID: 33548732
[TBL] [Abstract][Full Text] [Related]
2. Chemistry, Pharmacology and Therapeutic Potential of Swertiamarin - A Promising Natural Lead for New Drug Discovery and Development.
Muhamad Fadzil NS; Sekar M; Gan SH; Bonam SR; Wu YS; Vaijanathappa J; Ravi S; Lum PT; Dhadde SB
Drug Des Devel Ther; 2021; 15():2721-2746. PubMed ID: 34188450
[TBL] [Abstract][Full Text] [Related]
3. Molecular docking, antiproliferative and anticonvulsant activities of swertiamarin isolated from Enicostemma axillare.
Vaijanathappa J; Puttaswamygowda J; Bevanhalli R; Dixit S; Prabhakaran P
Bioorg Chem; 2020 Jan; 94():103428. PubMed ID: 31740047
[TBL] [Abstract][Full Text] [Related]
4. N-γ-(L-glutamyl)-L-selenomethionine shows neuroprotective effects against Parkinson's disease associated with SKN-1/Nrf2 and TRXR-1 in Caenorhabditis elegans.
Chang CH; Wei CC; Ho CT; Liao VH
Phytomedicine; 2021 Nov; 92():153733. PubMed ID: 34537465
[TBL] [Abstract][Full Text] [Related]
5. The Molecular Targets of Swertiamarin and its Derivatives Confer Anti- Diabetic and Anti-Hyperlipidemic Effects.
Patel N; Tyagi RK; Tandel N; Garg NK; Soni N
Curr Drug Targets; 2018; 19(16):1958-1967. PubMed ID: 29623834
[TBL] [Abstract][Full Text] [Related]
6. Wedelolactone Mitigates Parkinsonism Via Alleviating Oxidative Stress and Mitochondrial Dysfunction Through NRF2/SKN-1.
Sharma S; Trivedi S; Pandey T; Ranjan S; Trivedi M; Pandey R
Mol Neurobiol; 2021 Jan; 58(1):65-77. PubMed ID: 32894501
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid ameliorates C. elegans dopaminergic neurodegeneration with implications for ERK-MAPK signaling.
Kautu BB; Carrasquilla A; Hicks ML; Caldwell KA; Caldwell GA
Neurosci Lett; 2013 Apr; 541():116-9. PubMed ID: 23485787
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro immunomodulatory potential of swertiamarin isolated from Enicostema axillare (Lam.) A. Raynal that acts as an anti-inflammatory agent.
Saravanan S; Pandikumar P; Prakash Babu N; Hairul Islam VI; Thirugnanasambantham K; Gabriel Paulraj M; Balakrishna K; Ignacimuthu S
Inflammation; 2014 Oct; 37(5):1374-88. PubMed ID: 24736879
[TBL] [Abstract][Full Text] [Related]
9. A new HPTLC densitometric method for analysis of swertiamarin in Enicostemma littorale and commercial formulations.
Alam P; Ali M; Singh R; Shakeel F
Nat Prod Res; 2011 Jan; 25(1):17-25. PubMed ID: 21240756
[TBL] [Abstract][Full Text] [Related]
10. Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson's disease model.
Yan J; Yang Z; Zhao N; Li Z; Cao X
BMC Neurosci; 2019 Jun; 20(1):31. PubMed ID: 31208386
[TBL] [Abstract][Full Text] [Related]
11. n-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's disease.
Fu RH; Harn HJ; Liu SP; Chen CS; Chang WL; Chen YM; Huang JE; Li RJ; Tsai SY; Hung HS; Shyu WC; Lin SZ; Wang YC
PLoS One; 2014; 9(1):e85305. PubMed ID: 24416384
[TBL] [Abstract][Full Text] [Related]
12. Ferulic Acid Exerts Neuroprotective Effects via Autophagy Induction in
Long T; Wu Q; Wei J; Tang Y; He YN; He CL; Chen X; Yu L; Yu CL; Law BY; Wu JM; Qin DL; Wu AG; Zhou XG
Oxid Med Cell Longev; 2022; 2022():3723567. PubMed ID: 35242276
[TBL] [Abstract][Full Text] [Related]
13. Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease.
Zhu FD; Wang BD; Qin DL; Su XH; Yu L; Wu JM; Law BY; Guo MS; Yu CL; Zhou XG; Wu AG
CNS Neurosci Ther; 2024 Apr; 30(4):e14515. PubMed ID: 37905594
[TBL] [Abstract][Full Text] [Related]
14. Iridoid compound 10-O-trans-p-coumaroylcatalpol extends longevity and reduces α synuclein aggregation in Caenorhabditis elegans.
Shukla V; Phulara SC; Yadav D; Tiwari S; Kaur S; Gupta MM; Nazir A; Pandey R
CNS Neurol Disord Drug Targets; 2012 Dec; 11(8):984-92. PubMed ID: 23244417
[TBL] [Abstract][Full Text] [Related]
15. Swertiamarin, a secoiridoid glycoside modulates nAChR and AChE activity.
Pandey T; Smita SS; Mishra A; Sammi SR; Pandey R
Exp Gerontol; 2020 Sep; 138():111010. PubMed ID: 32590127
[TBL] [Abstract][Full Text] [Related]
16. p38 MAPK-SKN-1/Nrf signaling cascade is required for intestinal barrier against graphene oxide toxicity in Caenorhabditis elegans.
Zhao Y; Zhi L; Wu Q; Yu Y; Sun Q; Wang D
Nanotoxicology; 2016 Dec; 10(10):1469-1479. PubMed ID: 27615004
[TBL] [Abstract][Full Text] [Related]
17. Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro.
Hsu YL; Hung HS; Tsai CW; Liu SP; Chiang YT; Kuo YH; Shyu WC; Lin SZ; Fu RH
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638579
[TBL] [Abstract][Full Text] [Related]
18. Phytochemicals-induced hormesis protects Caenorhabditis elegans against α-synuclein protein aggregation and stress through modulating HSF-1 and SKN-1/Nrf2 signaling pathways.
Govindan S; Amirthalingam M; Duraisamy K; Govindhan T; Sundararaj N; Palanisamy S
Biomed Pharmacother; 2018 Jun; 102():812-822. PubMed ID: 29605769
[TBL] [Abstract][Full Text] [Related]
19. 2-Butoxytetrahydrofuran, Isolated from
Promtang S; Sanguanphun T; Chalorak P; Pe LS; Niamnont N; Sobhon P; Meemon K
ACS Chem Neurosci; 2024 Jun; 15(11):2182-2197. PubMed ID: 38726817
[TBL] [Abstract][Full Text] [Related]
20. The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans.
Bornhorst J; Chakraborty S; Meyer S; Lohren H; Brinkhaus SG; Knight AL; Caldwell KA; Caldwell GA; Karst U; Schwerdtle T; Bowman A; Aschner M
Metallomics; 2014 Mar; 6(3):476-90. PubMed ID: 24452053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
